Logo image of BGSF

BGSF INC (BGSF) Stock Fundamental Analysis

NYSE:BGSF - New York Stock Exchange, Inc. - US05601C1053 - Common Stock - Currency: USD

4.97  +0.04 (+0.81%)

Fundamental Rating

3

BGSF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. While BGSF seems to be doing ok healthwise, there are quite some concerns on its profitability. BGSF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BGSF has reported negative net income.
BGSF had a positive operating cash flow in the past year.
BGSF had positive earnings in 4 of the past 5 years.
BGSF had a positive operating cash flow in 4 of the past 5 years.
BGSF Yearly Net Income VS EBIT VS OCF VS FCFBGSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

BGSF has a worse Return On Assets (-0.86%) than 69.62% of its industry peers.
BGSF has a worse Return On Equity (-1.64%) than 69.62% of its industry peers.
BGSF has a Return On Invested Capital of 2.45%. This is in the lower half of the industry: BGSF underperforms 62.03% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BGSF is below the industry average of 13.65%.
The last Return On Invested Capital (2.45%) for BGSF is well below the 3 year average (9.31%), which needs to be investigated, but indicates that BGSF had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.86%
ROE -1.64%
ROIC 2.45%
ROA(3y)5.61%
ROA(5y)5.86%
ROE(3y)10.56%
ROE(5y)10.62%
ROIC(3y)9.31%
ROIC(5y)8.58%
BGSF Yearly ROA, ROE, ROICBGSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

Looking at the Operating Margin, with a value of 1.53%, BGSF is doing worse than 69.62% of the companies in the same industry.
In the last couple of years the Operating Margin of BGSF has declined.
BGSF has a Gross Margin (34.38%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BGSF has grown nicely.
Industry RankSector Rank
OM 1.53%
PM (TTM) N/A
GM 34.38%
OM growth 3Y21.65%
OM growth 5Y-9.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.85%
GM growth 5Y5.98%
BGSF Yearly Profit, Operating, Gross MarginsBGSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

5

2. Health

2.1 Basic Checks

BGSF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BGSF has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BGSF has more shares outstanding
BGSF has a worse debt/assets ratio than last year.
BGSF Yearly Shares OutstandingBGSF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
BGSF Yearly Total Debt VS Total AssetsBGSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

BGSF has an Altman-Z score of 2.61. This is not the best score and indicates that BGSF is in the grey zone with still only limited risk for bankruptcy at the moment.
BGSF has a Altman-Z score (2.61) which is in line with its industry peers.
BGSF has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
BGSF has a Debt to FCF ratio of 1.99. This is in the better half of the industry: BGSF outperforms 70.89% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that BGSF is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.55, BGSF is doing worse than 60.76% of the companies in the same industry.
Although BGSF does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.99
Altman-Z 2.61
ROIC/WACC0.27
WACC8.97%
BGSF Yearly LT Debt VS Equity VS FCFBGSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.75 indicates that BGSF should not have too much problems paying its short term obligations.
BGSF has a better Current ratio (1.75) than 70.89% of its industry peers.
BGSF has a Quick Ratio of 1.75. This is a normal value and indicates that BGSF is financially healthy and should not expect problems in meeting its short term obligations.
BGSF has a better Quick ratio (1.75) than 70.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
BGSF Yearly Current Assets VS Current LiabilitesBGSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

1

3. Growth

3.1 Past

The earnings per share for BGSF have decreased strongly by -114.71% in the last year.
The earnings per share for BGSF have been decreasing by -18.67% on average. This is quite bad
The Revenue for BGSF has decreased by -11.12% in the past year. This is quite bad
The Revenue has been growing slightly by 1.77% on average over the past years.
EPS 1Y (TTM)-114.71%
EPS 3Y69.23%
EPS 5Y-18.67%
EPS Q2Q%-129.17%
Revenue 1Y (TTM)-11.12%
Revenue growth 3Y14.78%
Revenue growth 5Y1.77%
Sales Q2Q%-14.73%

3.2 Future

BGSF is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -58.77% yearly.
Based on estimates for the next years, BGSF will show a decrease in Revenue. The Revenue will decrease by -3.79% on average per year.
EPS Next Y-148.57%
EPS Next 2Y-58.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.37%
Revenue Next 2Y-3.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BGSF Yearly Revenue VS EstimatesBGSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BGSF Yearly EPS VS EstimatesBGSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BGSF. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 46.41, BGSF can be considered very expensive at the moment.
72.15% of the companies in the same industry are cheaper than BGSF, based on the Price/Forward Earnings ratio.
BGSF's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE N/A
Fwd PE 46.41
BGSF Price Earnings VS Forward Price EarningsBGSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BGSF indicates a rather cheap valuation: BGSF is cheaper than 81.01% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BGSF indicates a rather cheap valuation: BGSF is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.23
EV/EBITDA 8.1
BGSF Per share dataBGSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

A cheap valuation may be justified as BGSF's earnings are expected to decrease with -58.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-58.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BGSF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BGSF INC

NYSE:BGSF (2/21/2025, 8:04:00 PM)

4.97

+0.04 (+0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-12 2025-03-12/amc
Inst Owners33.19%
Inst Owner Change-99.54%
Ins Owners3.71%
Ins Owner Change3.19%
Market Cap54.77M
Analysts82.5
Price Target12.24 (146.28%)
Short Float %0.23%
Short Ratio1.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.44
Dividend Growth(5Y)-15.04%
DP-241.24%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-174.09%
Min EPS beat(2)-185.78%
Max EPS beat(2)-162.39%
EPS beat(4)1
Avg EPS beat(4)-96.23%
Min EPS beat(4)-185.78%
Max EPS beat(4)34.8%
EPS beat(8)3
Avg EPS beat(8)56.94%
EPS beat(12)7
Avg EPS beat(12)56.07%
EPS beat(16)10
Avg EPS beat(16)46.64%
Revenue beat(2)0
Avg Revenue beat(2)-8.34%
Min Revenue beat(2)-9.73%
Max Revenue beat(2)-6.95%
Revenue beat(4)0
Avg Revenue beat(4)-5.89%
Min Revenue beat(4)-9.73%
Max Revenue beat(4)-3%
Revenue beat(8)1
Avg Revenue beat(8)-2.82%
Revenue beat(12)4
Avg Revenue beat(12)-5.87%
Revenue beat(16)4
Avg Revenue beat(16)-15.33%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)11.11%
EPS NQ rev (3m)11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-600%
Revenue NQ rev (1m)-1.24%
Revenue NQ rev (3m)-1.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 46.41
P/S 0.19
P/FCF 2.23
P/OCF 2.06
P/B 0.66
P/tB N/A
EV/EBITDA 8.1
EPS(TTM)-0.1
EYN/A
EPS(NY)0.11
Fwd EY2.15%
FCF(TTM)2.23
FCFY44.91%
OCF(TTM)2.41
OCFY48.46%
SpS25.56
BVpS7.53
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.86%
ROE -1.64%
ROCE 3.37%
ROIC 2.45%
ROICexc 2.45%
ROICexgc 6.94%
OM 1.53%
PM (TTM) N/A
GM 34.38%
FCFM 8.73%
ROA(3y)5.61%
ROA(5y)5.86%
ROE(3y)10.56%
ROE(5y)10.62%
ROIC(3y)9.31%
ROIC(5y)8.58%
ROICexc(3y)9.32%
ROICexc(5y)8.58%
ROICexgc(3y)64.05%
ROICexgc(5y)45.32%
ROCE(3y)12.65%
ROCE(5y)11.57%
ROICexcg growth 3Y163.33%
ROICexcg growth 5Y21.65%
ROICexc growth 3Y46.07%
ROICexc growth 5Y-10.8%
OM growth 3Y21.65%
OM growth 5Y-9.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.85%
GM growth 5Y5.98%
F-Score5
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.99
Debt/EBITDA 3.72
Cap/Depr 24.57%
Cap/Sales 0.69%
Interest Coverage 0.95
Cash Conversion 216.99%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z 2.61
F-Score5
WACC8.97%
ROIC/WACC0.27
Cap/Depr(3y)86.6%
Cap/Depr(5y)69.84%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.71%
EPS 3Y69.23%
EPS 5Y-18.67%
EPS Q2Q%-129.17%
EPS Next Y-148.57%
EPS Next 2Y-58.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.12%
Revenue growth 3Y14.78%
Revenue growth 5Y1.77%
Sales Q2Q%-14.73%
Revenue Next Year-12.37%
Revenue Next 2Y-3.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-73.2%
EBIT growth 3Y39.63%
EBIT growth 5Y-7.64%
EBIT Next Year247.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y350.2%
FCF growth 3Y-4.02%
FCF growth 5Y0.32%
OCF growth 1Y854.03%
OCF growth 3Y-2.89%
OCF growth 5Y2.04%